Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

Ji Yeon Lee; Pil Soo Sung

doi:10.5009/gnl240274

Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

Ji Yeon Lee
, Pil Soo Sung

Department of Internal Medicine

The Catholic University of Korea, College of Medicine
Catholic Univ. of Korea Coll. Med.

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	558-559
Number of pages	2
Journal	Gut and Liver
Volume	18
Issue number	4
DOIs	https://doi.org/10.5009/gnl240274
State	Published - Jul 2024

Access to Document

10.5009/gnl240274

Cite this

@article{859cba22a02243c384fa0fd814e43327,

title = "Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma",

author = "Lee, \{Ji Yeon\} and Sung, \{Pil Soo\}",

year = "2024",

month = jul,

doi = "10.5009/gnl240274",

language = "English",

volume = "18",

pages = "558--559",

journal = "Gut and Liver",

issn = "1976-2283",

publisher = "Editorial Office of Gut and Liver",

number = "4",

}

TY - JOUR

T1 - Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

AU - Lee, Ji Yeon

AU - Sung, Pil Soo

PY - 2024/7

Y1 - 2024/7

UR - https://www.scopus.com/pages/publications/85199015696

U2 - 10.5009/gnl240274

DO - 10.5009/gnl240274

M3 - Editorial

C2 - 39005198

AN - SCOPUS:85199015696

SN - 1976-2283

VL - 18

SP - 558

EP - 559

JO - Gut and Liver

JF - Gut and Liver

IS - 4

ER -

Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

Access to Document

Other files and links

Catholic University of Korea Researchers Yield New Study Findings on Liver Cancer (Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma)

Cite this

Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma

Access to Document

Other files and links

Press/Media

Catholic University of Korea Researchers Yield New Study Findings on Liver Cancer (Clinical Parameters Work Well as Predictive Factors for Atezolizumab and Bevacizumab Treatment in Hepatocellular Carcinoma)

Cite this